HemaSphere (Jul 2024)
The role of trephine bone marrow biopsies in the era of measurable residual disease—Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
- Nadine Kutsch,
- Sandra Robrecht,
- Anna Fink,
- Elisabeth Lange,
- Rudolf Weide,
- Michael G. Kiehl,
- Martin Sökler,
- Rudolf Schlag,
- Ursula Vehling‐Kaiser,
- Georg Köchling,
- Christoph Plöger,
- Michael Gregor,
- Torben Plesner,
- Michael R. Clausen,
- Ilske Oschlies,
- Matthias Ritgen,
- Marco Herling,
- Kirsten Fischer,
- Hartmut Döhner,
- Clemens‐Martin Wendtner,
- Karl‐Anton Kreuzer,
- Stephan Stilgenbauer,
- Michael Hallek,
- Sebastian Böttcher,
- Wolfram Klapper,
- Barbara Eichhorst
Affiliations
- Nadine Kutsch
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Sandra Robrecht
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Anna Fink
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Elisabeth Lange
- Department of Hematology and Oncology Evangelical Hospital Hamm Hamm Germany
- Rudolf Weide
- Practice for Hematology and Oncology Koblenz Germany
- Michael G. Kiehl
- Department of Internal Medicine Frankfurt (Oder) General Hospital Frankfurt/Oder Germany
- Martin Sökler
- Department II of Internal Medicine University Hospital Tübingen Tübingen Germany
- Rudolf Schlag
- Practice for Oncology Würzburg Germany
- Ursula Vehling‐Kaiser
- Oncology and Palliative Care, Dayclinic Landshut Landshut Germany
- Georg Köchling
- Private Oncology Practice Villingen‐Schwenningen Germany
- Christoph Plöger
- Private Oncology Practice Mannheim Germany
- Michael Gregor
- Division of Hematology Cantonal Hospital of Lucerne Lucerne Switzerland
- Torben Plesner
- Department of Hematology and University of Southern Denmark Vejle Hospital Vejle Denmark
- Michael R. Clausen
- Department of Hematology and University of Southern Denmark Vejle Hospital Vejle Denmark
- Ilske Oschlies
- Hematopathology Section Christian‐Albrechts‐University Kiel Kiel Germany
- Matthias Ritgen
- Department II of Internal Medicine University of Schleswig‐Holstein Kiel Germany
- Marco Herling
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Kirsten Fischer
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Hartmut Döhner
- Department III of Internal Medicine University Hospital of Ulm Ulm Germany
- Clemens‐Martin Wendtner
- Department III of Internal Medicine University Hospital, LMU Munich Germany
- Karl‐Anton Kreuzer
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Stephan Stilgenbauer
- Department of Hematology and Oncology Hospital STS AG Thun Thun Switzerland
- Michael Hallek
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- Sebastian Böttcher
- Department III of Internal Medicine Medicine—Hematology/Oncology/Palliative Care Rostock University Medical Center Rostock Germany
- Wolfram Klapper
- Hematopathology Section Christian‐Albrechts‐University Kiel Kiel Germany
- Barbara Eichhorst
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group University of Cologne Cologne Germany
- DOI
- https://doi.org/10.1002/hem3.126
- Journal volume & issue
-
Vol. 8,
no. 7
pp. n/a – n/a
Abstract
No abstracts available.
